Navigation Links
Inflammatory Substance May Boost Eye Trouble
Date:10/8/2007

C-reactive protein raises odds of age-related macular degeneration, experts say

MONDAY, Oct. 8 (HealthDay News) -- People with high blood levels of C-reactive protein, a substance associated with inflammation, may be at higher risk of developing age-related macular degeneration (AMD), a major cause of vision loss in older adults.

Dutch researchers collected blood samples and took photographs of the eyes of more than 4,900 people at risk for AMD. They then followed the group for an average of 7.7 years.

During that time, 658 of the participants were diagnosed with AMD -- 561 with initial stage AMD and 97 with advanced AMD.

As an individual's C-reactive protein level increased above the midpoint of the study group, the person became more and more likely to develop AMD, the researchers found.

The study is published in the October issue of the journal Archives of Ophthalmology.

The findings suggest that lowering C-reactive protein levels may help decrease AMD risk, the study authors said.

"A substance that can selectively inhibit C-reactive protein synthesis has not yet been developed, to our knowledge," wrote a team from Erasmus Medical Center, Rotterdam. "Smoking and high body mass index increase C-reactive protein levels. Moderate alcohol intake, diets with a low glycemic index and statin [drugs] and multivitamin use reduce C-reactive protein levels."

It's known that smoking and obesity increase the risk of AMD, which occurs when the macula -- the area at the back of the retina involved in sharp vision -- deteriorates over time.

More information

The U.S. National Eye Institute has more about AMD.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Oct. 8
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Inflammatory bowel disease linked to genetic abnormality
2. Safeguarding anti-inflammatory users from ulcers
3. Gel pares inflammatory activity throughout body
4. The Usage Of Anti-Inflammatory Drugs Questioned
5. Hope For Patients With Inflammatory Bowel Disease
6. FDA to bring about changes in Marketed Non-Steroidal Anti-Inflammatory Drugs
7. Anti-inflammatory drugs reduce the risk of oral cancer for smokers
8. Elevated Insulin Levels To Influence Levels Of Inflammatory Markers
9. Cannabinoids drug for inflammatory bowel
10. Cannabinoids - Antidepressant And Inflammatory Bowel Disease Treatment
11. Ambiguous Efficacy Of Opioid Drugs In Chronic Inflammatory Joint Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008).... Researchers at the University of Michigan Compr...ers that indicate which patients are more likely t...nsils. , Most notably, they found that cancers ...st responsive to current chemotherapy and radiatio...s of a certain growth factor receptor are the leas...
(Date:5/12/2008)...., May 12 /PRNewswire/ -- Keck Graduate Institute ...ncement ceremony will feature,the graduation of KG...ic,Tan, and the unveiling of KGI,s first donated a... achievement in becoming the,first graduate of our...nior,vice president for academic affairs, dean of ...
(Date:5/12/2008)... NASDAQ: CRME TSX: COM, VANCOUVER, May 12 /...DAQ: CRME / TSX: COM) today announced that it will... 2008 on the afternoon of Tuesday, May 13,2008. C...t at 4:30pm,Eastern (1:30pm Pacific) on that day t...call, please dial 416-641-6117 or,866-299-6655. Th...
(Date:5/12/2008)... Webcast Featuring Synchronized Slides at 5pm Toda... -- NxStage Medical, Inc.,(Nasdaq: NXTM ), a lead...today announced its financial results for the firs... first quarter of 2008 were $31.0 million, compare... $29.9 million in the fourth,quarter of 2007. Reve...
Breaking Medicine News(10 mins):Health News:HPV linked to better survival in tonsil, tongue cancer, U-M study finds 2Health News:HPV linked to better survival in tonsil, tongue cancer, U-M study finds 3Health News:KGI 2008 Commencement Features First PhD Graduate, Biotech Painting 2Health News:Cardiome To Release 2008 First Quarter Results 2Health News:Cardiome To Release 2008 First Quarter Results 3Health News:Cardiome To Release 2008 First Quarter Results 4Health News:NxStage Medical Reports First Quarter 2008 Results 2Health News:NxStage Medical Reports First Quarter 2008 Results 3Health News:NxStage Medical Reports First Quarter 2008 Results 4Health News:NxStage Medical Reports First Quarter 2008 Results 5Health News:NxStage Medical Reports First Quarter 2008 Results 6Health News:NxStage Medical Reports First Quarter 2008 Results 7Health News:NxStage Medical Reports First Quarter 2008 Results 8Health News:NxStage Medical Reports First Quarter 2008 Results 9Health News:NxStage Medical Reports First Quarter 2008 Results 10Health News:NxStage Medical Reports First Quarter 2008 Results 11
...ishing number and variety of microbes, including a...est food, mitigate disease, regulate fat storage,...For more than 100 years, scientists have known tha...their intestines. By applying sophisticated gene...
... struggles to deal with stagnation in its crucial ...nitiatives near the capital are providing clues on...farmers in India, where more than 70 percent of th... a living -- or else fall steadily into debt -- tr...
...se man who set a world record by wolfing down doze...e jaw injury due to his rigorous training, making ...shi said he can only open his mouth to make a gap ... after being diagnosed with jaw arthritis. In an e...
...he many survivors of the 2003 epidemic severe acut... but many suffered lingering mental health problem...Acute Respiratory syndrome (SARS) became a global ...n Asia, and the largest concentration of North Ame...
Other Medicine News:Health News:Revealing the Secrets of Gut Ecosystem 2Health News:Revealing the Secrets of Gut Ecosystem 3Health News:Organic Farms Provide a Clue for India's Struggling Farms 2Health News:Organic Farms Provide a Clue for India's Struggling Farms 3Health News:Japan's All-star Speed Eater Suffers Professional Injury 2Health News:SARS Patients Experience Mental Health Decline 2
(Date:5/12/2008)...NTA, May 12 /- GeoVax Labs,...d HIV/AIDS vaccine development,company, announced ...n,stock purchase agreement with Fusion Capital Fun..., The Company may sell up to $10 million of its c...er a 25-month period after the Securities and,Exch...
(Date:5/12/2008)...ides the Optimal Combination of Scaffolding, Deliv...bility, TEL AVIV, Israel, May 12 /- ...CE Mark for its Presillion(TM) CoCr Coronary Stent...ions with a technologically,innovative flexible cl... the superb scaffolding the unprecedented,balance ...
(Date:5/12/2008)...ADELPHIA, May 12 /PRNewswire-USNewswire/ -- GlaxoS...International Group (BIG), a leading,academic brea...groups, the,Spanish Breast Cancer Cooperative Grou...hase III study that will examine the role of TYKER...ALTTO (Neoadjuvant Lapatinib and/or,Trastuzumab Tr...
(Date:5/9/2008)..., Fla., May 9 /PRNewswire-USNewswire/ -- Osteoarth...ndition that affects almost 50,million people in t...,cartilage in bone joints. The novel investigation...oral analgesic, provided significant relief,for pa...treated with,placebo, and with fewer gastrointesti...
Breaking Medicine Technology:GeoVax Secures $10 Million Financing Commitment 2GeoVax Secures $10 Million Financing Commitment 3Medinol Receives CE Mark for Presillion(TM) Cobalt Chromium Coronary Stent on Rx System, an Advanced Evolution of the NIR(R) Family of Stents 2TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 2TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 3TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 4TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 6TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 7Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Friends of Warren Zevon To Play at Maverick Saloon Raising Awareness of Asbestos Cancer Mesothelioma 5200 1Friends of Warren Zevon To Play at Maverick Saloon Raising Awareness of Asbestos Cancer Mesothelioma 5200 2West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 1West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 2West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 3West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 4West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 5West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 6West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 7West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 8West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 9West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 10West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 11West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 12West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 13West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 14West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 15West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 16West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 17United Therapeutics Reports Third Quarter 2007 Financial Results 1642 1United Therapeutics Reports Third Quarter 2007 Financial Results 1642 2United Therapeutics Reports Third Quarter 2007 Financial Results 1642 3United Therapeutics Reports Third Quarter 2007 Financial Results 1642 4United Therapeutics Reports Third Quarter 2007 Financial Results 1642 5United Therapeutics Reports Third Quarter 2007 Financial Results 1642 6United Therapeutics Reports Third Quarter 2007 Financial Results 1642 7United Therapeutics Reports Third Quarter 2007 Financial Results 1642 8United Therapeutics Reports Third Quarter 2007 Financial Results 1642 9Neurocrine Biosciences and Dainippon Sumitomo Pharma 28DSP 29 Announce Agreement to Develop and Commercialize Indiplon in Japan 1640 1Neurocrine Biosciences and Dainippon Sumitomo Pharma 28DSP 29 Announce Agreement to Develop and Commercialize Indiplon in Japan 1640 2Neurocrine Biosciences and Dainippon Sumitomo Pharma 28DSP 29 Announce Agreement to Develop and Commercialize Indiplon in Japan 1640 3
...USTIN, Texas--(BUSINESS WIRE)--Apr 25, 2007 - Intr...ced the publication of,new preclinical data descri...s the anticancer activity of INGN 241. Inhibition ...r killing effects of,INGN 241 in cell culture and ... at Introgen and The University of Texas M. D. And...
...BOSTON, April 25, 2007 /PRNewswire-USNewswire/ -- ...polar disorder first,appear in childhood or adoles...o distinguish bipolar symptoms from those of other...d Mental Health,Letter. , Children, especially you...f distinct mood episodes of mania and depression.,...
Other Medicine Technology:Preclinical Studies Identify Novel Approach for Enhancing the,Anticancer Activity of Introgen's INGN 241 2Preclinical Studies Identify Novel Approach for Enhancing the,Anticancer Activity of Introgen's INGN 241 3Bipolar Disorder in Children Difficult to Diagnose, Reports the,Harvard Mental Health Letter 2
The design and concept of the Alpina knee allows the choice of implanting a PCL retaining or a posterior stabilized prosthesis intraoperatively, right up until the definitive implants are to be put i
Tibial distractor
...werSuite™ holmium laser combines excellent c...ecise, virtually bloodless procedures. It is also ...l bladder stones of all compositions, making it an...er light is transmitted through flexible fibers, i...
...werSuite™ holmium laser combines excellent c...ecise, virtually bloodless procedures. It is also ...l bladder stones of all compositions, making it an...er light is transmitted through flexible fibers, i...
Medicine Products: